Recovery of Impaired Endogenous Pain Modulation by Dopaminergic Medication in Parkinson's Disease

Mov Disord. 2020 Dec;35(12):2338-2343. doi: 10.1002/mds.28241. Epub 2020 Sep 18.

Abstract

Background: Of patients with Parkinson's disease (PD), 30% to 85% report pain. However, mechanisms underlying this pain remain unclear. In line with known neuroanatomical impairments, we hypothesized that pain in PD is caused by alterations in emotional-motivational as opposed to sensory-discriminative pain processing and that dopamine recovers the capacity for endogenous emotional-motivational pain modulation in patients with PD.

Methods: A total of 20 patients with PD played a random reward paradigm with painful heat stimuli in addition to assessments of pain sensitivity once with and once without levodopa.

Results: Levodopa increased endogenous pain inhibition in terms of perceived pain intensity and un/pleasantness compared with a medication off state. Higher clinical pain was associated with higher increases in pain inhibition. Levodopa did not affect heat pain threshold, tolerance, or temporal summation.

Conclusion: Patients with PD seem to be predominately impaired in emotional-motivational as opposed to sensory-discriminative pain processing. A differential understanding of pain in PD is urgently needed because effective treatment strategies are lacking. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: Parkinson's disease; dopamine; emotional-motivational pain processing; endogenous pain modulation; medial pain system.

MeSH terms

  • Dopamine Agents / therapeutic use
  • Humans
  • Levodopa / therapeutic use
  • Pain / drug therapy
  • Pain / etiology
  • Pain Threshold
  • Parkinson Disease* / complications
  • Parkinson Disease* / drug therapy

Substances

  • Dopamine Agents
  • Levodopa